Literature DB >> 26395117

Nutritional status and feeding-tube placement in patients with locally advanced hypopharyngeal cancer included in an induction chemotherapy-based larynx preservation program.

Alexandre Bozec1, Karen Benezery2, Emmanuel Chamorey3, Marc Ettaiche3, Clair Vandersteen4, Olivier Dassonville4, Gilles Poissonnet4, Jean-Christophe Riss4, Jean-Michel Hannoun-Lévi2, Marie-Eve Chand2, Axel Leysalle2, Esma Saada5, Anne Sudaka6, Juliette Haudebourg6, Christophe Hebert7, Marie-Noelle Falewee7, François Demard4, José Santini4, Frédéric Peyrade5.   

Abstract

The objective of the study is to evaluate the nutritional status and determine its impact on clinical outcomes in patients with locally advanced hypopharyngeal cancer included in an induction chemotherapy (ICT)-based larynx preservation program without prophylactic feeding-tube placement. All patients with locally advanced (T3/4, N0-3, M0) hypopharyngeal squamous cell carcinoma, technically suitable for total pharyngolaryngectomy, treated by docetaxel, cisplatin and 5-fluorouracil (TPF)-ICT for larynx preservation at our institution between 2004 and 2013, were included in this retrospective study. Patients' nutritional status was closely monitored. Enteral nutrition was used if and when a patient was unable to sustain per-oral nutrition and hydration. The impact of nutritional status on clinical outcomes was investigated in univariate and multivariate analysis. A total of 53 patients (42 men and 11 women, mean age = 58.6 ± 8.2 years) were included in this study. Six (11.3 %) patients had lost more than 10 % of their usual body weight before therapy. Compared with patients' usual weight, the mean maximum patient weight loss during therapeutic management was 8.7 ± 4.5 kg. Enteral nutrition was required in 17 patients (32 %). We found no influence of the tested nutritional status-related factors on response to ICT, toxicity of ICT, overall, cause-specific and recurrence-free survival, and on post-therapeutic swallowing outcome. Maximum weight loss was significantly associated with a higher risk of enteral tube feeding during therapy (p = 0.03) and of complications (grade ≥3, p = 0.006) during RT. Without prophylactic feeding-tube placement, approximately one-third of the patients required enteral nutrition. There was no significant impact of nutritional status on oncologic or functional outcomes.

Entities:  

Keywords:  Cancer; Enteral feeding tube; Functional outcome; Hypopharynx; Nutrition; Treatment

Mesh:

Substances:

Year:  2015        PMID: 26395117     DOI: 10.1007/s00405-015-3785-4

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  15 in total

1.  Ten years single institutional experience of treatment for advanced hypopharyngeal cancer in Kyoto University.

Authors:  Shigeru Hirano; Ichiro Tateya; Morimasa Kitamura; Shinpei Kada; Seiji Ishikawa; Tomoko Kanda; Shinzo Tanaka; Juichi Ito
Journal:  Acta Otolaryngol Suppl       Date:  2010-11

2.  The Dysphagia Outcome and Severity Scale.

Authors:  K H O'Neil; M Purdy; J Falk; L Gallo
Journal:  Dysphagia       Date:  1999       Impact factor: 3.438

3.  Malnutrition and quality of life in patients treated for oral or oropharyngeal cancer.

Authors:  Harriët Jager-Wittenaar; Pieter U Dijkstra; Arjan Vissink; Bernard F A M van der Laan; Rob P van Oort; Jan L N Roodenburg
Journal:  Head Neck       Date:  2010-09-07       Impact factor: 3.147

4.  Gastrostomy tube placement in patients with hypopharyngeal cancer treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence.

Authors:  Mihir K Bhayani; Katherine A Hutcheson; Denise A Barringer; Dianna B Roberts; Jan S Lewin; Stephen Y Lai
Journal:  Head Neck       Date:  2013-01-16       Impact factor: 3.147

5.  [Total pharyngolaryngectomy in the 21st century: indications, oncologic and functional outcomes].

Authors:  B Agopian; O Dassonville; E Chamorey; G Poissonnet; C S Pierre; F Peyrade; C Hebert; K Benezery; D Viel; A Sudaka; J Vallicioni; F Demard; J Santini; A Bozec
Journal:  Rev Laryngol Otol Rhinol (Bord)       Date:  2011

6.  Clinicopathologic risk factors for distant metastases from head and neck squamous cell carcinomas.

Authors:  X Li; B Di; Y Shang; Y Zhou; J Cheng; Z He
Journal:  Eur J Surg Oncol       Date:  2009-07-18       Impact factor: 4.424

7.  Cancer: disease and nutrition are key determinants of patients' quality of life.

Authors:  Paula Ravasco; Isabel Monteiro-Grillo; Pedro Marques Vidal; Maria E Camilo
Journal:  Support Care Cancer       Date:  2004-03-03       Impact factor: 3.603

8.  Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation.

Authors:  Yoann Pointreau; Pascal Garaud; Sophie Chapet; Christian Sire; Claude Tuchais; Jacques Tortochaux; Sandrine Faivre; Stephane Guerrif; Marc Alfonsi; Gilles Calais
Journal:  J Natl Cancer Inst       Date:  2009-03-24       Impact factor: 13.506

9.  Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary.

Authors:  Jean-Louis Lefebvre; K Kian Ang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-04-01       Impact factor: 7.038

10.  Enteral feeding outcomes after chemoradiotherapy for oropharynx cancer: a role for a prophylactic gastrostomy?

Authors:  Gillian F Williams; Mark T W Teo; Mehmet Sen; Karen E Dyker; Catherine Coyle; Robin J D Prestwich
Journal:  Oral Oncol       Date:  2011-12-29       Impact factor: 5.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.